[
    [
        {
            "time": "2021-09-22",
            "original_text": "沃森生物mRNA疫苗Ⅲ期临床尼泊尔获批 向千亿大蛋糕更进一步？",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA疫苗",
                    "Ⅲ期临床",
                    "尼泊尔",
                    "千亿市场"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物mRNA疫苗Ⅲ期临床尼泊尔获批 向千亿大蛋糕更进一步？",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-09-22",
            "original_text": "沃森生物：新冠mRNA 疫苗海外再获新进展",
            "features": {
                "keywords": [
                    "沃森生物",
                    "新冠mRNA疫苗",
                    "海外进展"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：新冠mRNA 疫苗海外再获新进展",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-09-22",
            "original_text": "医药行业周报：关节集采降价温和 板块情绪开始回暖",
            "features": {
                "keywords": [
                    "医药行业",
                    "集采降价",
                    "板块情绪",
                    "回暖"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业周报：关节集采降价温和 板块情绪开始回暖",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-09-22",
            "original_text": "沃森生物跌6.27% 中信证券半个月前喊买入目标价90元",
            "features": {
                "keywords": [
                    "沃森生物",
                    "股价下跌",
                    "中信证券",
                    "目标价"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物跌6.27% 中信证券半个月前喊买入目标价90元",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-22",
            "original_text": "沃森生物今日大宗交易成交35万股 成交价68.5元溢价1.11%",
            "features": {
                "keywords": [
                    "沃森生物",
                    "大宗交易",
                    "成交价",
                    "溢价"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物今日大宗交易成交35万股 成交价68.5元溢价1.11%",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 10,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-09-22",
            "original_text": "沃森生物(300142.SZ)：合作研发的新冠病毒mRNA疫苗获尼泊尔Ⅲ期临床试验批件",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA疫苗",
                    "尼泊尔",
                    "Ⅲ期临床试验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)：合作研发的新冠病毒mRNA疫苗获尼泊尔Ⅲ期临床试验批件",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-09-22",
            "original_text": "沃森生物：新型冠状病毒mRNA疫苗在尼泊尔进入Ⅲ期临床试验阶段",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA疫苗",
                    "尼泊尔",
                    "Ⅲ期临床试验"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：新型冠状病毒mRNA疫苗在尼泊尔进入Ⅲ期临床试验阶段",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-09-22",
            "original_text": "医药生物行业周报：把握景气度持续向上板块和个股估值修复机会",
            "features": {
                "keywords": [
                    "医药生物",
                    "景气度",
                    "估值修复"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周报：把握景气度持续向上板块和个股估值修复机会",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-09-17",
            "original_text": "A股融资融券日报：两融余额减少203.49亿（9月17日）",
            "features": {
                "keywords": [
                    "A股",
                    "融资融券",
                    "两融余额",
                    "减少"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "整体市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额减少203.49亿（9月17日）",
                "Correlation": 3,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        }
    ]
]